Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
44,668,215
-
Share change
-
+92,215
-
Total reported value
-
$10,266,093,815
-
Put/Call ratio
-
108%
-
Price per share
-
$229.72
-
Number of holders
-
517
-
Value change
-
+$36,774,240
-
Number of buys
-
257
-
Number of sells
-
237
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2024
As of 31 Mar 2024,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
517 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,668,215 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, FMR LLC, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and CITADEL ADVISORS LLC.
This page lists
518
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.